WBCIL at Vitafoods Europe 2026

WBCIL at Vitafoods Europe 2026: Where Liposomal Science Meets Global Opportunity

For the global nutraceutical industry, there is one date on the calendar that matters above all others in Europe: Vitafoods. And this year, West Bengal Chemical Industries Limited (WBCIL) will once again be at the centre of it.
WBCIL is proud to announce its participation at Vitafoods Europe 2026, taking place from 5–7 May 2026 at Fira Barcelona Gran Via, Barcelona, Spain. As one of India’s most established pharmaceutical and nutraceutical API manufacturers — with over 64 years of manufacturing experience and WHO-GMP, ISO, and HACCP certifications — WBCIL arrives not merely as an exhibitor, but as a science-led ingredient partner ready to shape the next generation of high-bioavailability formulations.

• Event: Vitafoods Europe 2026
• Dates: 5–7 May 2026
• Venue: Fira Barcelona Gran Via, Barcelona, Spain
• WBCIL Booth Visit us — contact wbcil@wbcil.com to connect

Why Vitafoods Europe 2026 Matters

Vitafoods Europe is the world’s premier nutraceutical trade event. The 2026 edition is expected to bring together over 15,000 industry professionals — including R&D scientists, procurement heads, product developers, brand owners, and regulatory experts — alongside more than 600 global exhibitors representing 130+ nations. With over 95% of attendees holding direct purchasing or decision-making authority, it is the most commercially concentrated event in the nutraceutical calendar.

For a manufacturer like WBCIL, whose liposomal APIs serve B2B partners across 35+ countries, Vitafoods Europe represents the ideal intersection of science communication, partnership building, and global market access.

What WBCIL Will Showcase at Vitafoods 2026

WBCIL’s exhibit will spotlight its flagship LipoEdge platform — the company’s dedicated liposomal science and formulation brand — alongside its broader portfolio of pharmaceutical-grade APIs, chelated minerals, and specialty nutraceuticals.

Attendees at the WBCIL booth can expect:

• Live demonstrations of liposomal nutraceutical APIs, including LipoEdge Vitamin C and LipoEdge Glutathione — with validated encapsulation efficiencies above 91%, up to 4x bioavailability improvement, and sub-200 nm particle engineering
• Showcase of multi-mineral liposomal blends and next-generation APIs targeting cognitive health, beauty-from-within, immune support, and active lifestyle formulations
• Mini-seminars and technical conversations on liposomal formulation science — from phospholipid bilayer architecture to zeta potential, PDI, and clinical bioavailability data
• Engagement with WBCIL’s R&D and business development teams for co-formulation discussions, sample requests, and regulatory documentation support
• Insights into WBCIL’s powdered liposomal technology — a manufacturing breakthrough that enables stable, water-dispersible liposomal APIs compatible with capsules, sachets, functional beverages, and cosmeceutical bases

WBCIL approaches liposomal formulation as molecular engineering — not cosmetic blending. Every LipoEdge API is characterised by HPLC, FTIR, DLS, DSC, SEM, and XPS before it reaches a B2B partner’s formulation table.

Building on a Strong Vitafoods Track Record

WBCIL’s participation at Vitafoods Europe 2026 builds on an outstanding performance at the 2025 edition in Barcelona, where the company was named a top exhibitor to watch in the liposomal nutraceuticals category. At that event, visitors experienced live demonstrations of liposomal serums and glutathione gummies, and industry media featured WBCIL prominently in event roundups.

The company has also participated in Vitafoods Europe 2024, where it welcomed representatives from The Coca-Cola Company, Nanologistics, Hemofarm A.D., and NBIOTECH, and received a visit from His Excellency Mr. Mridul Kumar, Ambassador of the Indian Embassy in Switzerland — a recognition of WBCIL’s standing as a globally significant ingredient innovator.

In 2026, the ambition is higher: deeper formulation partnerships, expanded market reach across Europe and beyond, and the launch of new liposomal innovations aligned with the industry’s most pressing demands — clean labels, clinical efficacy, and regulatory compliance.

Why Partner with WBCIL?

For formulators and brand owners evaluating ingredient partners at Vitafoods Europe 2026, WBCIL offers a combination that is rare in the B2B ingredient market:

• 64+ years of pharmaceutical-grade API manufacturing — from Kolkata and Dahej, Gujarat
• WHO-GMP, ISO, HACCP, and FSSAI certifications for global regulatory compliance
• Published, peer-reviewed scientific validation for liposomal products — not just internal claims
• Full technical data stack: HPLC purity, DLS particle sizing, zeta potential, FTIR, DSC, SEM
• Export reach to 35+ countries with DMF documentation and regulatory support
• Customisable APIs for nutraceutical, cosmeceutical, pharmaceutical, and functional beverage applications

Consumers today demand transparency, clean labels, and visible results. WBCIL’s liposomal nutraceuticals deliver all three — and Vitafoods Europe 2026 is where you can see exactly how.

Meet WBCIL at Vitafoods Europe 2026

Whether you are a formulator looking for a clinically validated liposomal API, a brand owner seeking a WHO-GMP B2B ingredient partner, or an R&D leader exploring the next frontier of bioavailability science, WBCIL’s team in Barcelona will have something meaningful to discuss.

Dates: 5–7 May 2026 | Venue: Fira Barcelona Gran Via, Barcelona, Spain
Contact: wbcil@wbcil.com | Website: www.wbcil.com

We look forward to seeing you in Barcelona.